BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33106998)

  • 21. NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis.
    Hu H; Li B; Chen H; Fan G; Ye Z; Ji S; Yu X; Xu X; Qin Y
    Mol Carcinog; 2024 Feb; 63(2):195-208. PubMed ID: 37846815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.
    Devine DJ; Rostas JW; Metge BJ; Das S; Mulekar MS; Tucker JA; Grizzle WE; Buchsbaum DJ; Shevde LA; Samant RS
    Oncogene; 2014 May; 33(20):2620-8. PubMed ID: 23770854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klotho inhibits the capacity of cell migration and invasion in cervical cancer.
    Chang B; Kim J; Jeong D; Jeong Y; Jeon S; Jung SI; Yang Y; Kim KI; Lim JS; Kim C; Lee MS
    Oncol Rep; 2012 Sep; 28(3):1022-8. PubMed ID: 22710352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 25. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation.
    Wang JY; Jiang MW; Li MY; Zhang ZH; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Jin HL; Ma J; Jin Y; Zuo HX; Jin X
    J Nutr Biochem; 2022 Feb; 100():108899. PubMed ID: 34748924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
    Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
    Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
    Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M
    Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis.
    Jiang C; Xu R; Li XX; Wang YY; Liang WQ; Zeng JD; Zhang SS; Xu XY; Yang Y; Zhang MY; Wang HY; Zheng XFS
    Cell Cycle; 2017 Sep; 16(18):1673-1682. PubMed ID: 28841361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
    Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
    Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling.
    Wang DW; You D; Dong J; Liu TF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):496-506. PubMed ID: 30720156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
    Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
    Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
    Yuan Y; Ye HQ; Ren QC
    Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.
    Jiang Y; Ren W; Wang W; Xia J; Gou L; Liu M; Wan Q; Zhou L; Weng Y; He T; Zhang Y
    Oncol Rep; 2017 Nov; 38(5):2597-2606. PubMed ID: 29048651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.